| Literature DB >> 35744752 |
Catarina Gouveia1,2, Ana Subtil3,4, Susana Norte5, Joana Arcangelo5, Madalena Almeida Santos6, Rita Corte-Real6, Maria João Simões7, Helena Canhão2,3, Delfin Tavares5.
Abstract
(1) Background: We aim to identify clinical and laboratorial parameters to distinguish Kingella kingae from pyogenic septic arthritis (SA). (2)Entities:
Keywords: Kingella kingae; acute septic arthritis; pyogenic infections
Year: 2022 PMID: 35744752 PMCID: PMC9227297 DOI: 10.3390/microorganisms10061233
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
K. kingae and typical pathogen arthritis in children < 5 years.
| TOTAL | Typical Pathogens |
| ||
|---|---|---|---|---|
| Age, months, median (IQR) | 16.8 (12–24) | 15.3 (12–24) | 18 (9.6–36) | 0.623 |
| Age < 36 months, n (%) | 64 (85.3) | 41 (93.2) | 23 (74.2) | 0.043 |
| Male gender, n (%) | 52 (69.3) | 32 (72.7) | 20 (64.5) | 0.448 |
| Symptom duration at admission, days, median (IQR) | 3 (2–5) | 3 (2–5) | 2 (1–6) | 0.220 |
| Fever duration, n (%) | 0.5 (0–2) | 0 (0–2) | 2 (0.75–7.5) | <0.001 |
| Fever at admission, n (%) | 42/74 (56.8) | 16/43 (37.2) | 26 (83.9) | <0.001 |
| Fever > 48 h of antibiotics, n (%) | 7/64 (10.9) | 0 (0) | 7/23 (30.4) | <0.001 |
| Septic look, n (%) | 6/71(8.4) | 0 (0) | 6/28 (21.4) | 0.003 |
| Osteoarthritis, n (%) | 10 (13.3) | 4 (9.1) | 6 (19.4) | 0.3 |
| Disseminated infection, n (%) | 3 (4) | 0 (0) | 3 (9.6) | 0.067 |
| Abscesses, n (%) | 3 (4) | 1 (2.3) | 2 (6.5) | 0.566 |
| Myositis, n (%) | 10/73 (13.7) | 4/43 (9.3) | 6/30 (20) | 0.3 |
| WBC count, cells/mm3, median (IQR) | 13,900 (10,800–18,200) | 12,700 (10,300–17,100) | 15,200 (11,300–19,700) | 0.58 |
| WBC < 14,000/mm3, n (%) | 38/71 (53.5) | 24/40 (60) | 14 (41.9) | 0.214 |
| Platelet’s count, cells/mm3, median (IQR) | 505,000 (363,000–571,100) | 474,500 (376,000–530,500) | 554,000 (346,000 690,000) | 0.133 |
| CRP peak, mg/L, median (IQR) | 61.6 (30–147) | 40.5 (18–69) | 162 (93.7–215) | <0.001 |
| CRP < 100, mg/L, n (%) | 47 (62.7) | 39 (88.6) | 8 (25.8) | <0.001 |
| CRP at 48–96 h, median (IQR) | 27.4 (9.7–79) | 16.3 (5–29) | 73.3 (30–150) | <0.001 |
| ESR peak, mm/h, median (IQR) | 61 (42–79) | 54 (39–68.5) | 68 (59–94) | 0.003 |
| Admitted to ICU, (%) | 3 (4) | 0 (0) | 3 (9.7) | 0.067 |
| ≥2 surgeries, n (%) | 16 (21.3) | 7 (15.9) | 9 (29) | 0.172 |
| Days of IV antibiotic, median (IQR) | 10 (5–15) | 6 (4–10) | 16(13–27) | <0.001 |
| Days of total antibiotic, median (IQR) | 25 (21–32.5) | 21 (21–26) | 32 (26–44) | <0.001 |
| LOS, days, median (IQR) | 10 (5–16) | 6 (4–11) | 16 (11–23) | <0.001 |
| Complications, n (%) | 15 (20) | 5 (11.4) | 10 (32.3) | 0.026 |
| Sequelae at 6 months, n (%) | 3/73(4.1) | 0/43 | 3/30 (10) | 0.065 |
Predicted model to distinguish K. kingae and typical arthritis pathogens in children < 5 years *.
| Predicted | ||||
|---|---|---|---|---|
| Observed | No | yes | % Correct | |
|
| No | 26 | 5 | 83.9 |
| Yes | 5 | 38 | 88.4 | |
| 86.5 | ||||
* Based on age > 6 months ≤ 2 years, apyrexia and CRP < 100 mg/L.
Figure 1AUC assessed by ROC curves was capable to differentiate K. kingae arthritis from typical pathogens, for this model.